Today: 21 May 2026
IonQ stock slips as Korea’s KISTI finalizes 100-qubit quantum system deal
29 December 2025
1 min read

IonQ stock slips as Korea’s KISTI finalizes 100-qubit quantum system deal

NEW YORK, December 29, 2025, 11:38 ET — Regular session

  • IonQ shares fell 1.7% in late-morning trading after the company announced a South Korea system deal.
  • IonQ said it will deliver a 100-qubit “Tempo 100” quantum system to national research institute KISTI. IonQ Investors
  • Investors are watching for contract value and delivery timing; the company did not disclose financial terms.

Shares of IonQ Inc fell 1.7% to $45.22 in late-morning trading on Monday after the quantum computing company said it finalized an agreement with South Korea’s Korea Institute of Science and Technology Information (KISTI) to deliver a 100-qubit system.

The announcement matters because hardware deliveries are a visible test of whether quantum-computing developers can turn research partnerships into paid deployments of machines that cost far more than typical cloud subscriptions. IonQ is one of a small set of U.S.-listed pure plays that can swing sharply on contract headlines.

Investors had little to go on beyond the headline: IonQ did not disclose the financial terms or a delivery timeline, leaving traders to wait for evidence of when the contract could translate into revenue.

IonQ said the agreement covers a “Tempo 100” quantum system that will be integrated into KISTI-6, a high-performance computing (HPC) cluster dubbed “HANGANG.” The company said the setup would be the country’s first onsite hybrid quantum-classical integration. IonQ Investors

A qubit — short for quantum bit — is the basic unit of information in a quantum computer, while “HPC” refers to supercomputer-style clusters used for heavy scientific workloads. A hybrid system links a quantum processor with conventional computers so users can route parts of a job to each where it fits best. IonQ Investors

“This is a defining moment for both IonQ and South Korea,” Niccolo de Masi, IonQ’s chairman and chief executive, said in the statement. IonQ Investors

IonQ said the system will be accessible through a secure private cloud environment, allowing remote access for researchers, universities and enterprise users in South Korea. KISTI will lead development and operation of a quantum computing service and research platform, with Megazone Cloud named as a partner on the project.

The stock traded between $44.72 and $46.74 on Monday and had seen about 8.6 million shares change hands by late morning.

Broader markets were weaker, with the S&P 500 ETF SPY down about 0.5% and the Nasdaq 100 tracker QQQ down about 0.7% in the same window.

Other quantum-computing names were mixed: Rigetti Computing fell about 3.1%, D-Wave Quantum rose about 0.9%, and Quantum Computing Inc slipped about 2.4%.

IonQ pointed to other Asia-Pacific ties in its announcement, including collaborations in Japan and partnerships in South Korea with SK Telecom and Hyundai Motor, among others.

With contract value and timing undisclosed, traders are likely to focus next on whether the KISTI deal shows up in booked revenue in upcoming quarterly results, and whether IonQ can add similar system deliveries as 2026 begins.

Stock Market Today

  • Analysts Predict OneSource Specialty Pharma to Breakeven by 2027
    May 21, 2026, 3:29 AM EDT. OneSource Specialty Pharma Limited, a biopharmaceutical firm listed on NSE, currently valued at ₹214 billion, reported a ₹738 million loss in its latest financial year ending March 2026. Industry analysts project the company will continue to post a small loss in 2026 but achieve profitability with ₹4.1 billion earnings by 2027. This forecast implies an ambitious average annual growth rate of 104%, raising questions about execution risks. The company's modest debt level, comprising 22% of equity, suggests prudent capital management and reduced financial risk. With growth expectations high, OneSource's path to breakeven within a year or less depends on successful expansion and product development milestones in the biopharma sector.

Latest articles

Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
Sensex edges higher as oil slips, rupee firms

Sensex edges higher as oil slips, rupee firms

21 May 2026
Indian shares trimmed early gains but stayed higher late Thursday morning, with the Nifty 50 up 0.30% and Sensex up 0.20% as oil prices fell and the rupee rebounded. Apollo Hospitals climbed on a 36% profit jump, while Lenskart and Grasim Industries rose after strong earnings. The rupee strengthened after RBI intervention. Ola Electric fell as brokerages stayed cautious.
Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom
Previous Story

Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom

New expressway makes Ahmedabad-to-Salangpur Hanuman temple trip faster — even before official opening
Next Story

New expressway makes Ahmedabad-to-Salangpur Hanuman temple trip faster — even before official opening

Go toTop